Persistence Rate With Subcutaneous Biologic Therapies in Patients With Ankylosing Spondylitis (As)

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.2635
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Persistence Rate With Subcutaneous Biologic Therapies in Patients With Rheumatoid Arthritis (Ra)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Sexual Function in Male Patients With Ankylosing Spondylitis

International Journal of Impotence Research
Urology
2011English

A New Cardiac Autonomic Function Predictor (Heart Rate Turbulence) in Patients With Ankylosing Spondylitis

Turkish Journal of Rheumatology
2010English

Evaluation of Hearing Loss in Patients With Ankylosing Spondylitis

Erciyes Tip Dergisi
Medicine
2014English

Periodontal Disease in Patients With Ankylosing Spondylitis: Myth or Reality?

Revista de Chimie
SurfacesMaterials ScienceEngineeringMaterials ChemistryFilmsCoatingsChemistry
2017English

Management of Cervical Spine Injuries in Patients With Ankylosing Spondylitis

Journal of Neurosurgery
SurgeryNeurology
1990English

Comparison of HLA-B*27 Subtypes Between Chinese Patients With Ankylosing Spondylitis and Non-Ankylosing Spondylitis Carriers

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Serum Chitotriosidase and Neopterin Levels in Patients With Ankylosing Spondylitis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2019English

Incidence of Inflammatory Bowel Disease in Patients With Ankylosing Spondylitis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy